A federal court jury in Wilmington last week awarded Johnson & Johnson’s Lifescan Inc. unit more than $5.9 million after finding that Home Diagnostics Inc. and MIT Development Corp. infringed on a Lifescan patent for technology used in blood-sugar monitors.
After deliberating for a little more than eight hours, the five-woman, two-man jury on Friday awarded Lifescan the damages for lost royalties on technology the company said was used without permission by rivals Home Diagnostics and MIT.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
